Literature DB >> 15802212

The life-threatening complications of dermatologic therapies.

Edith Orion1, Hagit Matz, Ronni Wolf.   

Abstract

Dermatologists use a variety of systemic drugs, some of which can cause severe adverse reactions and even fatalities. Ivermectin, a well-tolerated drug, can cause severe neurological side effects, whereas metronidazole, in high cumulative doses, has been associated with convulsions and rarely with hepatotoxicity. Dapsone is associated with frequent hematologic side effects, such as methemoglobinemia, hemolysis, and anemia. Although hepatotoxicity is rare and usually mild and reversible with the new antifungal agents, severe cutaneous reactions (such as toxic epidermal necrolysis, Stevens-Johnson syndrome, and anaphylaxis) have been reported. Even a relatively safe drug such as acyclovir has been reported to be the cause of renal failure and neurotoxicity. Retinoids can cause not so benign "benign" intracranial hypertension. Methotrexate can cause not only liver toxicity, but also myelosuppression and pancytopenia, which may be acute and life threatening. Nephrotoxicity is a well-recognized side effect of cyclosporine, whereas thrombotic thrombocytopenic purpura, which is associated with high morbidity and mortality, is less well known. Dermatologists should be familiar with these and other severe adverse reactions of the most popular and most used systemic medications of our trade.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802212     DOI: 10.1016/j.clindermatol.2004.06.013

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  7 in total

Review 1.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

2.  Inhibitory activity and mechanism of silver nanoparticles against herpes simplex virus type 1.

Authors:  Xuanhe Pan; Yapeng Zhang; Yiming Zhao; Siqi Yao; Chaxiang Guan; Linqian Wang; Liyu Chen
Journal:  Arch Virol       Date:  2022-06-01       Impact factor: 2.685

Review 3.  Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.

Authors:  Elisabeth Chroni; Alexandra Monastirli; Dionysios Tsambaos
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

4.  Moxidectin toxicity in senescence-accelerated prone and resistant mice.

Authors:  Vanessa K Lee; Asheesh K Tiwary; Prachi Sharma-Reddy; Karen A Lieber; Douglas K Taylor; Deborah M Mook
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

5.  Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome.

Authors:  Blaine W Robinson; Nai-Kong V Cheung; Christos P Kolaris; Suresh C Jhanwar; John K Choi; Neil Osheroff; Carolyn A Felix
Journal:  Blood       Date:  2008-01-14       Impact factor: 22.113

6.  Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis.

Authors:  Serge Lavoie; Isabelle Côté; André Pichette; Charles Gauthier; Michaël Ouellet; Francine Nagau-Lavoie; Vakhtang Mshvildadze; Jean Legault
Journal:  BMC Complement Altern Med       Date:  2017-02-22       Impact factor: 3.659

7.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.